# reload+after+2024-01-22 05:47:03.752290
address1§19925 Stevens Creek Boulevard
address2§Suite 100
city§Cupertino
state§CA
zip§95014
country§United States
phone§408 501 8881
fax§408 904 6270
website§https://revivapharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is based in Cupertino, California.
fullTimeEmployees§10
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Laxminarayan  Bhat Ph.D.', 'age': 58, 'title': 'Founder, CEO, President & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 560000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Narayan  Prabhu', 'age': 51, 'title': 'Chief Financial Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 412500, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
beta§-0.014
currency§USD
exchange§NCM
quoteType§EQUITY
shortName§Reviva Pharmaceuticals Holdings
longName§Reviva Pharmaceuticals Holdings, Inc.
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c781d567-a211-3345-b342-e6464dc20dcd
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§0.382
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
